MARSHALL WACE, LLP - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$4,444,665
-16.5%
85,639
-3.6%
0.01%
-10.0%
Q2 2023$5,324,687
+346.5%
88,804
+268.2%
0.01%
+233.3%
Q1 2023$1,192,493
-31.2%
24,120
-20.6%
0.00%
-25.0%
Q4 2022$1,733,786
+53.2%
30,380
+26.0%
0.00%
+100.0%
Q3 2022$1,132,000
+25.8%
24,1200.0%0.00%0.0%
Q2 2022$900,000
+24.8%
24,1200.0%0.00%
+100.0%
Q1 2022$721,000
-12.7%
24,1200.0%0.00%
-50.0%
Q4 2021$826,00024,1200.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders